ECE2023 Poster Presentations Endocrine-related Cancer (62 abstracts)
Treatment of childhood-onset craniopharyngioma patients using proton beam therapy vs photon-based radiation therapy in the prospective Kraniopharyngeom 2007 trial
Carsten Friedrich 1 , Svenja Boekhoff 1 , Panjarat Sowithayasakul 1,2 , Maria Eveslage 3 , Julia Beckhaus 1 , Brigitte Bison 4 , Beate Timmermann 5 & Hermann Müller 1
1Klinikum Oldenburg AöR, Oldenburg, Germany; 2Srinakharinwirot University, Thailand; 3University of Münster, Münster, Germany; 4University Hospital Augsburg, Augsburg, Germany; 5Essen University Hospital, Essen, Germany
Background: Proton beam therapy (PBT) compared to photon-based radiotherapy (XRT) offers the benefit to administer lower radiation doses to critical organs thereby possibly minimizing the risk of sequelae in patients with residual craniopharyngiomas (CP) after hypothalamus-sparing surgery. The validation in large CP patient cohorts is still pending.
Methods: Of 290 childhood-onset CP patients included 2007-2019 in the prospective multicenter trial Kraniopharyngeom 2007, 99 (34%) received external RT (65% PBT, 35% XRT). Outcome was compared between the different groups in terms of overall (OS) and event-free survival (EFS), quality of life (QoL using PEDQOL), functional capacity (FMH), and auxological data (BMI and height SDS) one, three and five years after irradiation/CP diagnosis.
Results: PBT became the predominant irradiation technique during the study period (used in 23% and 77% of all irradiated patients registered within the first and second half of the enrollment period, respectively). PBT as well as XRT were associated with high (P<0.001) EFS (PBT: 0.917 ± 0.040; XRT: 0.940 ± 0.041) compared to non-RT (EFS: 0.669 ± 0.044). OS was similar in all groups. No differences between PBT, XRT and non-RT CP patients concerning functional capacity and anthropometric parameters (height SDS, BMI SDS) have been obtained. Only in the PEDQOL domain “physical function”, proxy-assessed QoL was lower one year after PBT when compared to XRT treated and non-irradiated CP patients. PBT is similar efficient in preventing relapses in childhood-onset CP patients. During follow-up, clinically relevant differences between PBT and XRT in terms of QoL, functional capacity and degree of obesity as a marker of hypothalamic syndrome were not detectable.
Conclusions: While PBT is increasingly applied, studies on larger CP cohorts with longer follow-up after RT are warranted to analyze, whether it can prevent sequelae such as hypothalamic syndrome and severe obesity compared to XRT.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more